Yuan Li

18.2k total citations
534 papers, 11.8k citations indexed

About

Yuan Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yuan Li has authored 534 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Pulmonary and Respiratory Medicine, 164 papers in Molecular Biology and 133 papers in Oncology. Recurrent topics in Yuan Li's work include Lung Cancer Treatments and Mutations (112 papers), Lung Cancer Diagnosis and Treatment (77 papers) and Lung Cancer Research Studies (48 papers). Yuan Li is often cited by papers focused on Lung Cancer Treatments and Mutations (112 papers), Lung Cancer Diagnosis and Treatment (77 papers) and Lung Cancer Research Studies (48 papers). Yuan Li collaborates with scholars based in China, United States and Sweden. Yuan Li's co-authors include Haiquan Chen, Yihua Sun, Yunjian Pan, Yang Zhang, Lei Shen, Hang Li, Haichuan Hu, Ting Ye, Rui Wang and Xiaoyang Luo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Yuan Li

500 papers receiving 11.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuan Li China 54 4.7k 4.3k 3.1k 2.8k 1.3k 534 11.8k
Marc K. Halushka United States 56 4.4k 0.9× 2.4k 0.6× 1.8k 0.6× 2.2k 0.8× 1.7k 1.3× 215 11.8k
Alice P. Chen United States 50 4.7k 1.0× 2.0k 0.5× 4.4k 1.4× 2.8k 1.0× 891 0.7× 310 11.2k
Anders Bjartell Sweden 61 4.3k 0.9× 7.3k 1.7× 2.5k 0.8× 3.0k 1.1× 1.5k 1.1× 345 13.5k
Kwun M. Fong Australia 56 6.1k 1.3× 6.2k 1.4× 4.4k 1.4× 2.5k 0.9× 729 0.6× 236 12.9k
Nico van Zandwijk Netherlands 64 4.4k 0.9× 8.3k 1.9× 4.8k 1.6× 3.1k 1.1× 1.1k 0.8× 301 14.8k
Dino Amadori Italy 60 4.5k 1.0× 3.1k 0.7× 6.7k 2.2× 4.3k 1.5× 1.6k 1.3× 351 14.2k
Fei‐Fei Liu Canada 65 6.9k 1.5× 1.9k 0.4× 3.5k 1.1× 4.3k 1.5× 2.4k 1.9× 388 15.4k
Malcolm V. Brock United States 45 4.4k 0.9× 2.5k 0.6× 2.3k 0.8× 1.5k 0.5× 1.3k 1.0× 187 8.8k
Alicia Samuels United States 8 3.4k 0.7× 3.5k 0.8× 4.7k 1.5× 1.6k 0.6× 2.1k 1.6× 8 11.4k
Jiafu Ji China 53 5.5k 1.2× 5.3k 1.2× 4.3k 1.4× 2.5k 0.9× 3.0k 2.3× 486 14.4k

Countries citing papers authored by Yuan Li

Since Specialization
Citations

This map shows the geographic impact of Yuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Li more than expected).

Fields of papers citing papers by Yuan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Li. The network helps show where Yuan Li may publish in the future.

Co-authorship network of co-authors of Yuan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yuan Li. A scholar is included among the top collaborators of Yuan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuan Li. Yuan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Donghai, Zhen Huang, Lifeng Zheng, et al.. (2025). A highly biosimilar synthetic Calculus Bovis enhances cerebral blood flow and provides neuroprotection against ischemic stroke. Journal of Ethnopharmacology. 355(Pt A). 120602–120602.
3.
Lu, Lu, et al.. (2024). Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction. Journal of Pharmaceutical Analysis. 15(5). 101138–101138. 2 indexed citations
4.
Li, Yuan, et al.. (2024). Application value of early lung cancer screening based on artificial intelligence. SHILAP Revista de lepidopterología. 17(3). 100982–100982. 1 indexed citations
6.
Tang, Huiling, Yanfang Tan, Yuan Li, et al.. (2023). Extraction and characterization of polysaccharide from fermented mycelia of Coriolus versicolor and its efficacy for treating nonalcoholic fatty liver disease. International Journal of Biological Macromolecules. 248. 125951–125951. 20 indexed citations
7.
Lin, Ying, Bo Yu, Hongyu Zhang, et al.. (2023). Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor. Journal of Cancer Research and Clinical Oncology. 149(11). 8663–8671. 20 indexed citations
8.
Wang, Chenyu, et al.. (2023). CFD Simulation and Optimal Design of a New Parabolic–Shaped Guided Valve Tray. Separations. 10(4). 267–267. 1 indexed citations
9.
Zhang, Ying, Qi Wang, Hui Xie, et al.. (2023). Incidence of liver cancer among Asian Americans and native Asians. HPB. 25. S116–S116.
10.
Deng, Chaoqiang, Yang Zhang, Fangqiu Fu, et al.. (2021). Genetic-pathological prediction for timing and site-specific recurrence pattern in resected lung adenocarcinoma. European Journal of Cardio-Thoracic Surgery. 60(5). 1223–1231. 10 indexed citations
11.
Zheng, Qiang, Yan Huang, Xin Zeng, et al.. (2020). Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China. Journal of Cancer Research and Clinical Oncology. 147(5). 1547–1556. 27 indexed citations
12.
Shi, Linlin, Yuan Li, Yuan Wang, & Yi Feng. (2015). MDG-1, an Ophiopogon polysaccharide, regulate gut microbiota in high-fat diet-induced obese C57BL/6 mice. International Journal of Biological Macromolecules. 81. 576–583. 87 indexed citations
13.
Pan, Yunjian, Yang Zhang, Yuan Li, et al.. (2014). Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma. Annals of Surgical Oncology. 21(S4). 490–496. 25 indexed citations
15.
Wang, Rui, Yunjian Pan, Chenguang Li, et al.. (2014). Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas. Journal of Thoracic Oncology. 9(6). 760–768. 46 indexed citations
16.
Lu, Yanxia, Yuan Li, Xiaolei Xue, et al.. (2014). Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c -Sox2–Negative Feedback Loop Mechanism. Clinical Cancer Research. 20(10). 2631–2642. 83 indexed citations
17.
Wang, Rui, Yuan Li, Haichuan Hu, et al.. (2014). FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer. Clinical Cancer Research. 20(15). 4107–4114. 116 indexed citations
18.
19.
Wang, Rui, Yunjian Pan, Chenguang Li, et al.. (2012). The Use of Quantitative Real-Time Reverse Transcriptase PCR for 5′ and 3′ Portions of ALK Transcripts to Detect ALK Rearrangements in Lung Cancers. Clinical Cancer Research. 18(17). 4725–4732. 75 indexed citations
20.
Li, Yuan. (2004). Immunohistochemical Localization of Toll-like Receptors 4 in Pancreas. Huaxi yixue. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026